JBIO Jade Biosciences, Inc.
$17.89▼ -6.53%
Healthcare
Other
After hours
$17.89▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.25M
Avg Volume (10D) 810.5K
Key Metrics & Fundamentals
Market Cap
$1.14B
P/E Ratio
–
Div Yield
–%
52W Range
6.91 - 28.00
% vs 50 MA
-15.26%
% vs 200 MA
-1.42%
RSI-14
30.9
MACD Histogram
-0.3900
Beta (1Y vs SPY)
1.29
Free Cash Flow
-$43.66M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$58.91M
COGS
–
Operating Exp
$58.92M
Operating Income
-$58.92M
EBIT
-$58.92M
Pretax Income
-$55.75M
Net Income
-$55.77M
EPS (Diluted)
-0.76
Price & Volume History
Loading chart…
Recent News
Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says
MT Newswires · Sep 4, 2026 3:17 PM
Jade Biosciences to Participate in Upcoming Conferences
GlobeNewswire · Sep 1, 2026 11:00 AM
Wedbush Adjusts Price Target on Jade Biosciences to $47 From $45, Keeps Outperform Rating
MT Newswires · Aug 10, 2026 3:43 PM
Jade Biosciences' Q2 Loss Narrows
MT Newswires · Aug 10, 2026 11:25 AM
Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics
MT Newswires · Jul 2, 2026 11:02 AM
Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?
Insider Monkey · Jun 30, 2026 1:21 PM
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
GlobeNewswire · Jun 26, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See JBIO's money flow as a full page
Social Sentiment
No Reddit posts found for JBIO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.